M. G. Salluzzo

发表

NF-kB1 gene expression in Down syndrome patients

P. Bosco, C. Romano, C. Romano, 2015, Neurological Sciences.

Differential expression of PARP1 mRNA in leucocytes of patients with Down’s syndrome

P. Bosco, C. Romano, F. Caraci, 2011, Journal of Genetics.

Neurobiological links between depression and AD: The role of TGF‐&bgr;1 signaling as a new pharmacological target

F. Nicoletti, F. Drago, A. Copani, 2018, Pharmacological research.

Expression of Phosphodiesterase 4B cAMP‐Specific Gene in Subjects With Cryptorchidism and Down's Syndrome

P. Bosco, C. Romano, M. Vinci, 2016, Journal of clinical laboratory analysis.

Reduced mitochondrial mRNA expression in dementia with Lewy bodies

Mariagiovanna Cantone, R. Ferri, M. Salemi, 2017, Journal of the Neurological Sciences.

Poly (ADP-ribose) polymerase 1 expression in fibroblasts of Down syndrome subjects

P. Bosco, C. Romano, C. Tirolo, 2013 .

Poly (ADP-ribose) polymerase-1 (PARP-1) −410C/T polymorphism in Sicilian patients with Parkinson's disease

P. Bosco, M. C. Morale, F. Cosentino, 2016, Journal of the Neurological Sciences.

KIF21A mRNA expression in patients with Down syndrome

P. Bosco, C. Romano, C. Romano, 2013, Neurological Sciences.

Pericentrin expression in Down’s syndrome

P. Bosco, C. Romano, F. Drago, 2013, Neurological Sciences.

Long non-coding RNA GAS5 expression in patients with Down syndrome

C. Romano, Giovanna Marchese, A. Cordella, 2020, International journal of medical sciences.

CASP3 protein expression by flow cytometry in Down’s syndrome subjects

P. Bosco, C. Romano, C. Romano, 2013, Human Cell.

Role and Dysregulation of miRNA in Patients with Parkinson’s Disease

G. M. Ventola, R. Ferri, G. Lanza, 2022, International journal of molecular sciences.

Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment

Santo Di Nuovo, Filippo Caraci, Raffaele Ferri, 2013, Current genomics.

A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease

G. M. Ventola, R. Ferri, G. Lanza, 2022, International journal of molecular sciences.

CCR3 gene overexpression in patients with Down syndrome

C. Romano, M. Ravo, A. Cordella, 2021, Molecular Biology Reports.

Role of long non-coding RNAs in Down syndrome patients: a transcriptome analysis study

C. Romano, M. Ravo, A. Calogero, 2021, Human Cell.

Cerebellar degeneration-related protein 1 expression in fibroblasts of patients affected by down syndrome

C. Romano, C. Tirolo, G. Rappazzo, 2020 .

A peculiar VNTR in the cystathionine β-synthase gene is a risk factor for Down Syndrome.

P. Bosco, M. C. Morale, C. Romano, 2015, Cellular and molecular biology.

SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down’s syndrome subjects with undescended testes

P. Bosco, C. Romano, F. Nicoletti, 2009, Journal of Genetics.

Killer-specific secretory (Ksp37) gene expression in subjects with Down’s syndrome

P. Bosco, C. Romano, M. C. Morale, 2016, Neurological Sciences.

Mitochondrial mRNA expression in fibroblasts of Down syndrome subjects

C. Romano, R. Russo, M. Salemi, 2018, Human Cell.

Methylation analysis of multiple genes in blood DNA of Alzheimer’s disease and healthy individuals

P. Bosco, F. Coppedè, L. Migliore, 2015, Neuroscience Letters.

Uncharacterized RNAs in Plasma of Alzheimer’s Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power

R. Ferri, F. Caraci, F. Cosentino, 2020, International journal of molecular sciences.

Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects

P. Bosco, C. Romano, F. Zolezzi, 2012, Journal of Genetics.

The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression

P. Bosco, R. Ferri, F. Drago, 2012, European Neuropsychopharmacology.

Humanin gene expression in fibroblast of Down syndrome subjects

C. Romano, C. Tirolo, R. Ferri, 2020, International journal of medical sciences.

LDOC1 expression in fibroblasts of patients with Down syndrome

P. Bosco, C. Romano, M. Vinci, 2015 .

LDOC 1 expression in fibroblasts of patients with Down syndrome

P. Bosco, C. Romano, M. Vinci, 2015 .

Humanin gene expression in subjects with Parkinson’s disease

Mariagiovanna Cantone, R. Ferri, B. Lanuzza, 2023, Molecular Biology Reports.

Expression of miR-132 in Down syndrome subjects

C. Romano, M. Salemi, C. Barone, 2018, Human Cell.

Association study of COX-2 (PTGS2) –765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease

P. Bosco, A. Calogero, M. Salemi, 2014, Archives of medical science : AMS.

Study of the MDM2 -410T-G polymorphism (rs2279744) by pyrosequencing in mothers of Down Syndrome subjects

C. Romano, M. Salemi, C. Barone, 2020, Human Cell.

A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers

C. Romano, M. C. Morale, C. Romano, 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.

C. Romano, F. Coppedè, L. Migliore, 2017, Journal of Alzheimer's disease : JAD.

Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects

P. Bosco, C. Romano, F. Zolezzi, 2014, Journal Genetika.

Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis

L. Delrosso, M. G. Salluzzo, M. Mogavero, 2024, iScience.

Pain-Free Alpha-Synuclein Detection by Low-Cost Hierarchical Nanowire Based Electrode

M. Scuderi, G. Lanza, S. Mirabella, 2024, Nanomaterials.

A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease

B. Lanuzza, G. Lanza, M. Tripodi, 2023, Biomedicines.

Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls

G. M. Ventola, G. Lanza, M. Salemi, 2024, International journal of molecular sciences.